Distinct biological activities of recombinant forms of human interleukin-2 in vivo
β Scribed by A. B. Lentsch; Koji Nakagawa; Hiroyuki Yoshidome; Alexandra Gerassimides; Frederick N. Miller; Michael J. Edwards
- Publisher
- Springer-Verlag
- Year
- 1997
- Tongue
- English
- Weight
- 257 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background The natural oncotropism and oncotoxicity of vectors derived from the autonomous parvovirus, minute virus of mice (prototype strain) [MVM(p)], combined with the immunotherapeutic properties of cytokine transgenes, make them interesting candidates for cancer gene therapy. ## Methods
A phase-I study of the recombinant, non-mutagenized interleukin 2 (rlL2, Bioleukin'") was performed in 12 melanoma patients (Pts). From 100 to 800 pg/m2 of rlL2 were administered by i.v. bolus injection, TID for 4-8 days. Side-effects included fever, malaise, low serum K + and C a + + values, electr
## Abstract The extraordinary genetic diversity and immune evasion of human immunodeficiency virus (HIV) pose significant challenges for vaccine development and antiretroviral therapy efficacy. The objective of this study was to characterize the molecular profile of HIVβ1 epidemic in Salvador, Bahi